Insider Transactions in Q3 2021 at Ideaya Biosciences, Inc. (IDYA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,384
-6.33%
|
$307,368
$27.54 P/Share
|
|
Sep 08
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,384
+6.09%
|
$79,688
$7.7 P/Share
|
|
Sep 07
2021
|
Paul A. Stone Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-16.19%
|
$67,500
$27.42 P/Share
|
|
Sep 07
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
116
-0.15%
|
$3,132
$27.46 P/Share
|
|
Sep 07
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
116
+0.15%
|
$464
$4.31 P/Share
|
|
Sep 02
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.26%
|
$250,000
$25.09 P/Share
|
|
Aug 09
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,500
-5.76%
|
$264,500
$23.24 P/Share
|
|
Aug 09
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+1.47%
|
$6,000
$4.31 P/Share
|
|
Jul 27
2021
|
Jason Throne Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$250,000
$25.17 P/Share
|
|
Jul 27
2021
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$130,000
$13.34 P/Share
|
|
Jul 27
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.19%
|
$250,000
$25.15 P/Share
|
|
Jul 27
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.5%
|
$50,000
$5.62 P/Share
|
|
Jul 06
2021
|
Jason Throne Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-70.5%
|
$220,000
$22.42 P/Share
|
|
Jul 06
2021
|
Jason Throne Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.64%
|
$100,000
$10.18 P/Share
|
|
Jul 06
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,500
-0.75%
|
$33,000
$22.48 P/Share
|
|
Jul 06
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+1.47%
|
$9,000
$6.92 P/Share
|